首页|期刊导航|Cancer Innovation|Metronomic Chemotherapy in Breast Cancer:Unleashing the Potential of Combination Regimens

Metronomic Chemotherapy in Breast Cancer:Unleashing the Potential of Combination Regimens

Jiaxuan Liu Hongnan Mo Qiao Li Marina Elena Cazzaniga Fei Ma

Cancer Innovation2025，Vol.4Issue(6)：P.97-111,15.

Cancer Innovation2025，Vol.4Issue(6)：P.97-111,15.DOI:10.1002/cai2.70035

Metronomic Chemotherapy in Breast Cancer:Unleashing the Potential of Combination Regimens

Jiaxuan Liu ¹Hongnan Mo ¹Qiao Li ¹Marina Elena Cazzaniga ²Fei Ma¹

作者信息

1. Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
2. Department of Medicine and Surgery,University of Milano-Bicocca,Monza,Italy Phase 1 Unit,Fondazione IRCCS San Gerardo dei Tintori,Monza,Italy
折叠

摘要

关键词

angiogenesis inhibitors/antineoplastic combined chemotherapy protocols/breast neoplasms/immunotherapy/metronomic chemotherapy/tumor microenvironment

分类

医药卫生

引用本文复制引用

Jiaxuan Liu,Hongnan Mo,Qiao Li,Marina Elena Cazzaniga,Fei Ma..Metronomic Chemotherapy in Breast Cancer:Unleashing the Potential of Combination Regimens[J].Cancer Innovation,2025,4(6):P.97-111,15.

基金项目

funded by National Key Research and Development Program of China(Grant number 2024YFA1107400). （Grant number 2024YFA1107400）

Cancer Innovation

ISSN：2770-9191

访问量1

下载量0

段落导航